Option Care Health Confirms Strong Q4 and Full Year 2024 Financial Results, Reaffirms 2025 Guidance

OPCH
October 03, 2025

Option Care Health, Inc. reported its final financial results for the fourth quarter and full year ended December 31, 2024. For the fourth quarter, net revenue reached $1.35 billion, marking a 19.7% increase year-over-year. Adjusted EBITDA was $118.5 million, and adjusted diluted earnings per share stood at $0.44.

For the full year 2024, the company achieved net revenue of $5.00 billion, representing a 16% increase compared to the prior year. Full-year adjusted EBITDA was $443.5 million, and adjusted diluted earnings per share was $1.56. These results align with the preliminary figures previously announced, demonstrating consistent operational execution.

Option Care Health also reaffirmed its financial guidance for the full year 2025, expecting revenue between $5.4 billion and $5.6 billion, adjusted EBITDA between $455 million and $470 million, and adjusted earnings per share between $1.61 and $1.70. This guidance reflects the company's outlook despite anticipated market dynamics, including the previously disclosed STELARA pricing adjustments.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.